Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 06, 2020

SELL
$126.05 - $152.76 $345,377 - $418,562
-2,740 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $314,460 - $440,189
-3,000 Reduced 52.26%
2,740 $398,000
Q3 2018

Nov 06, 2018

SELL
$112.11 - $134.54 $156,954 - $188,356
-1,400 Reduced 19.61%
5,740 $772,000
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $717,070 - $843,162
7,140
7,140 $781,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Stone Ridge Asset Management LLC Portfolio

Follow Stone Ridge Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Ridge Asset Management LLC with notifications on news.